Kliinisen farmakologian yks.

Julkaisut 2007
Publications 2007

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 de Leon MJ et al. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.
2 Grönholm P et al. Neural correlates of naming newly learned objects in MCI.
3 Haltia LT et al. Effects of intravenous glucose on dopaminergic function in the human brain in vivo.
4 Haltia LT et al. Brain white matter expansion in human obesity and the recovering effect of dieting.
5 Helin-Salmivaara A et al. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population.
6 Helin-Salmivaara A et al. Risk of upper gastrointestinal events with the use of various NSAIDs: A case-control study in a general population.
7 Hilli J et al. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
8 Huupponen R. Inotrooppiset lääkkeet.
9 Huupponen R. Lääkkeen annos, pitoisuus ja vaste.
10 Huupponen R. Ruoansulatuskanavan lääkkeet.
11 Huupponen R, Laitinen JT. Kannabinoidit - muutakin kuin huumetta.
12 Huupponen R, Raunio H. Farmakokinetiikka.
13 Huupponen R, Rouru J. Tietoruutu: Insuliini.
14 Hynninen V-V et al. Effect of voriconazole on the pharmacokinetics of diclofenac.
15 Ingman K. Pharmacological Modulation of the Alcohol Drinking of AA rats, an Animal Model of High-alcohol Drinking.
16 Kemppainen NM et al. Pet amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment .
17 Klaukka T et al. Kipulääkityksessä tapahtuu: ibuprofeeni, parasetamoli ja glukosamiini nousussa, koksibit laskussa.
18 Klaukka T et al. Miksi rahoittajan lääke menestyy tutkimuksissa kilpailijaa paremmin?
19 Lampela P et al. Adverse drug effects in elderly people - a disparity between clinical examination and adverse effects self-reported by the patient.
20 Lampela P et al. Iäkäs potilas tunnistaa lääkkeidensä haittavaikutukset huonosti.
21 Laurila JMM et al. The second extracellular loop of alpha-2A-adrenoceptors contributes to the binding of yohimbine analogues.
22 Lautamäki R et al. Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease.
23 Lyoo CH et al. Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on Parkinsonian motor deficits and freezing of gait.
24 Maksimow A et al. Assessing the depth of dexmedetomidine-induced sedation with electroencephalogram (EEG)-based spectral entropy.
25 Moulin CJA et al. Brain function during multi-trial learning in mild cognitive impairment: A PET activation study.
26 Mäenpää M et al. The effects of surgical levels of sevoflurane and propofol anaesthesia on heart rate variability.
27 Puustinen J et al. Associations between use of benzodiazepines or related drugs and health, physical abilities and cognitive function. A non-randomised clinical study in the elderly.
28 Rahi M et al. Placental transfer of quetiapine in relation to P-glycoprotein activity.
29 Raitakari OT et al. Variation of the transcription factor 7-like 2 (TCF7L2) gene predicts impaired fasting glucose in healthy young adults.
30 Rantamäki M et al. Do carriers of POLG mutation W748S have disease manifestations?
31 Raunio H, Huupponen R. Vierasainemetabolia.
32 Rinne J et al. Alzheimerin taudin lääkkeet.
33 Rouru J, Huupponen R. Diabeteslääkkeet.
34 Saari T. Effects of Cytochrome P450 Enzyme Inhibitors on the Metabolism of Drugs Used in Anaesthesiology.
35 Saari TI et al. Voriconazole and fluconazole increase the exposure to oral diazepam.
36 Saari TI et al. Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects.
37 Scheinin M. Tietoruutu: Lääkeaineiden sitoutuminen reseptoriin.
38 Scheinin M. Adrenoseprotoriagonistit (sympatomimeetit).
39 Scheinin M. Lääkeaineiden vaikutusmekanismit: reseptorit.
40 Scheinin NM et al. Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans.
41 Turpeinen M et al. Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites.
42 Vihinen PP et al. Serum VEGF-C is associated with metastatic site in patients with malignant melanoma.
43 Viikari LA et al. Relationship between leptin and C-reactive protein in young Finnish adults.

Julkaisutietokanta 22.10.2008 Publications Data Base 22.10.2008